
Biofrontera
(NASDAQ) BFRIW
Biofrontera Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$41.71M
Net Income (TTM)
$10.54M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.04
Volume
2,731
Open
$0.06
Price
$0.04
Volume
2,731
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.03 - $0.28
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.04
Volume
2,731
Open
$0.06
Previous Close
$0.06
Daily Range
$0.06 - $0.06
52-Week Range
$0.03 - $0.28
BFRIW News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biofrontera
BFRIW Financials
Key Financial Metrics (TTM)
Gross Margin
76%
Operating Margin
-27%
Net Income Margin
-25%
Return on Equity
0%
Return on Capital
-68%
Return on Assets
-37%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
2.73K
Short Interest
0.00%
Avg. Volume
1.18K
Financials (TTM)
Gross Profit
$31.59M
Operating Income
$11.35M
EBITDA
$10.48M
Operating Cash Flow
$13.36M
Capital Expenditure
$2.00K
Free Cash Flow
$13.36M
Cash & ST Invst.
$6.39M
Total Debt
$6.16M
Biofrontera Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$17.10M
+36.2%
Gross Profit
$14.37M
+97.1%
Gross Margin
84.01%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
92
N/A
Net Income
$5.64M
+504.0%
EBITDA
$4.78M
+525.5%
Quarterly Fundamentals
Net Cash
$231.00K
-76.7%
Accounts Receivable
$7.29M
+37.2%
Inventory
$1.43M
-78.5%
Long Term Debt
$5.83M
+33.3%
Short Term Debt
$332.00K
-39.4%
Return on Assets
-36.89%
N/A
Return on Invested Capital
-68.07%
N/A
Free Cash Flow
$2.38M
-133.3%
Operating Cash Flow
$2.38M
-133.6%